Programming lasting health
HAYA Therapeutics is a precision medicine company developing RNA-guided programmable therapeutics that target the regulatory genome — the 98% of the genome that doesn't code for proteins — to reverse disease-driving cell states. The company's platform integrates multimodal functional genomics with proprietary computational tools to discover and drug long non-coding RNAs (lncRNAs) that causally drive fibrotic and other serious diseases.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2025
Create a free account to see which investors have funded this company.
Create Free Account
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
